There’s no such thing as a free lunch…. This adage is over 50 years old, and the Office of Inspector General for Health & Human Services (OIG) wants to remind doctors that it remains true.
The pharmaceutical and medical device
Latest from Destination: Health Law - Page 3
Sarah Churchill Llamas Moderates Panel Discussion at the Texas Life Science Venture Forum
Today, November 12, Shareholder Sarah Churchill Llamas moderated the panel discussion “Successful Raises and Investor Considerations” at the Texas Life Science Venture Forum, hosted by Rice Alliance for Technology and Entrepreneurship and BioHouston. The panel discussed advice for entrepreneurs/inventors that
Understanding the Basics of Cooperation Credit in False Claims Act Matters
It’s no secret that the Department of Justice has made the False Claims Act (“FCA”) a priority for years. Last month, we discussed why regulatory changes in response to Covid-19 (e.g., STARK waivers) could provide additional bases for the government
Issues in Life Science Leases
As landlords and tenants continue to navigate the uncertainties of traditional office and retail properties in the era of COVID, one asset type that has emerged as more resilient in this new environment is life science real estate.[1] The spaces utilized
Hotel Conversions to Assisted Living in the Wake of COVID-19
How do you take a negative and turn it into a positive? COVID-19 has made answering this question very difficult, as the pandemic continues to have a negative and in some cases long lasting and devastating impact on people’s daily
Exploring Preferential Rights in Hospital Ground Leases
Introduction
This article examines the different types of preferential rights in ground leases for medical office buildings, and examines strategies in drafting preferential rights provisions to protect the interests of both ground lessors and ground lessees. Ground leases are a
How HHS Information Blocking Regulations Apply to Healthcare Providers
Background
The U.S. Department of Health and Human Services (HHS) recently finalized transformative rules that will give patients unprecedented safe, secure access to their health data. The rules are issued by the HHS Office of the National Coordinator for Health
Do Covid-19 Regulatory Changes Pose an Increased Risk of Fraud and Abuse Liability for Healthcare Providers?
Regulatory developments—such as the Stark Law blanket waivers and the OIG’s enforcement deferral for use of the waivers—have helped healthcare providers during the COVID-19 crisis, but healthcare fraud remains a prime target of the DOJ and the OIG (in addition
COVID Recovery – Providing Quality Healthcare and Staying Ahead of the COVID-19 Curve—Complicated!
In this on demand webinar Shareholder Kevin Wood will cover how medical practices’ can stay ahead of the curve in the COVID environment. This presentation is from the MGMA Texas virtual Annual Meeting that took place September 8-11.
If You Received Provider Relief Funds Under the CARES Act, Are You Preparing Adequate Support for Your Use of the Funds?
Among the multitude of relief options under the CARES Act, the U.S. Department of Health & Human Services (HHS) allocated provider relief funds (PRF) to healthcare providers. Phase I in late April saw healthcare providers receive $50 billion in